Published in BMJ on November 09, 2002
Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med (2009) 7.89
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46
Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J Natl Cancer Inst (2009) 4.87
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation (2010) 2.49
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2010) 2.41
Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ (2010) 2.40
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol (2011) 2.15
Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs. Br J Clin Pharmacol (2016) 2.02
Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull (2009) 1.95
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf (2010) 1.78
Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia. Pharmacoepidemiol Drug Saf (2011) 1.63
Sudden deaths in psychiatric patients. J Clin Psychiatry (2011) 1.53
QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ (2013) 1.40
Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf (2008) 1.30
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf (2013) 1.24
In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol (2006) 1.19
New Generation Antipsychotic Drugs and QTc Interval Prolongation. Prim Care Companion J Clin Psychiatry (2003) 1.13
Cisapride and ventricular arrhythmia. Br J Clin Pharmacol (2008) 1.13
All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry (2009) 1.09
Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database. Pharmacoepidemiol Drug Saf (2008) 1.09
Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol (2009) 1.08
Cellular basis of drug-induced torsades de pointes. Br J Pharmacol (2008) 1.02
Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards. Br J Clin Pharmacol (2004) 0.99
Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan. PLoS One (2014) 0.99
Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol. Br J Clin Pharmacol (2004) 0.95
Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD). Curr Neuropharmacol (2008) 0.95
Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study. J Am Heart Assoc (2015) 0.93
Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study. Eur Heart J (2014) 0.89
The association between antipsychotic agents and the risk of myocardial infarction: a systematic review. Br J Clin Pharmacol (2011) 0.89
QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine. J Med Toxicol (2007) 0.86
Preparing for safety issues following drug approval: pre-approval risk management considerations. Ther Adv Drug Saf (2013) 0.86
Mortality after discharge from long-term psychiatric care in Scotland, 1977-94: a retrospective cohort study. BMC Public Health (2003) 0.85
Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States. J Clin Exp Cardiolog (2013) 0.85
Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders. Pharmacotherapy (2011) 0.84
Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients. Pharmacoepidemiol Drug Saf (2008) 0.81
Arrhythmias and sudden death in patients taking antipsychotic drugs. BMJ (2002) 0.81
Response of i(kr) and HERG currents to the antipsychotics tiapride and sulpiride. Korean J Physiol Pharmacol (2010) 0.81
Persistence of Antipsychotic Treatment in Elderly Dementia Patients: A Retrospective, Population-Based Cohort Study. Drugs Real World Outcomes (2016) 0.80
Impact of Age and Sex on QT Prolongation in Patients Receiving Psychotropics. Can J Psychiatry (2015) 0.80
A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia. Schizophr Bull (2007) 0.80
New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania. Neuropsychiatr Dis Treat (2013) 0.79
Molecular analysis of potassium ion channel genes in sudden death cases among patients administered psychotropic drug therapy: are polymorphisms in LQT genes a potential risk factor? J Hum Genet (2013) 0.78
Gender difference in QTc prolongation of people with mental disorders. Ann Gen Hosp Psychiatry (2004) 0.78
QTc and psychopharmacs: are there any differences between monotherapy and polytherapy. Ann Gen Psychiatry (2007) 0.76
Antipsychotic Medications and Risk of Acute Coronary Syndrome in Schizophrenia: A Nested Case-Control Study. PLoS One (2016) 0.75
Drug-Induced QT Prolongation And Torsades de Pointes. P T (2017) 0.75
Simulation study of confounder-selection strategies. Am J Epidemiol (1993) 12.76
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet (2000) 6.78
Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry (2001) 4.04
Comparison of National Death Index and World Wide Web death searches. Am J Epidemiol (2000) 3.05
Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol (1995) 2.17
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience. Eur J Clin Pharmacol (2000) 2.05
Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus. Eur J Clin Pharmacol (2001) 1.45
The risk of malignancy associated with psoriasis. Arch Dermatol (2001) 1.42
Sudden cardiac death and antipsychotic drugs: do we know enough? Arch Gen Psychiatry (2001) 1.32
Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias. Expert Opin Pharmacother (2000) 1.21
Risk of selected serious cardiac events among new users of antihistamines. Clin Ther (1996) 1.17
Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica (1984) 1.11
Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol (1988) 1.09
Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs Aging (2000) 1.05
A comparison of several methods to test for the existence of a monotonic dose-response relationship in clinical and epidemiological studies. Stat Med (2001) 0.96
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care (2011) 5.63
The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis (2010) 5.34
Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med (2003) 5.09
Prevalence of the metabolic syndrome and overweight among adults in China. Lancet (2005) 5.05
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med (2003) 4.40
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol (2003) 4.27
Prevalence, awareness, treatment, and control of hypertension in china. Hypertension (2002) 4.18
Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol (2006) 4.12
Design of a national distributed health data network. Ann Intern Med (2009) 4.09
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation (2010) 3.78
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol (2004) 3.43
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40
Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation (2005) 3.28
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
Statin use and the risk of 10 cancers. Epidemiology (2007) 3.17
Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14
Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol (2005) 3.11
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage (2003) 3.05
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood (2010) 2.93
Clinical risk factors for primary graft failure following lung transplantation. Chest (2003) 2.92
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
The FDA and drug safety: a proposal for sweeping changes. Arch Intern Med (2006) 2.74
Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry (2003) 2.69
Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int (2010) 2.59
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). Am J Psychiatry (2010) 2.57
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS (2006) 2.57
The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med (2005) 2.57
A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation. J Neurosci Methods (2009) 2.55
Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology (2012) 2.54
Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl (2005) 2.53
Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA (2003) 2.51
Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol (2002) 2.39
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol (2011) 2.36
Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control (2008) 2.35
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med (2005) 2.34
The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol (2007) 2.32
A prospective study of risk factors for erectile dysfunction. J Urol (2006) 2.25
A test of financial incentives to improve warfarin adherence. BMC Health Serv Res (2008) 2.23
Antibiotics, acne, and Staphylococcus aureus colonization. Arch Dermatol (2011) 2.22
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression. J Clin Epidemiol (2007) 2.19
Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation (2012) 2.19
Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med (2013) 2.16
Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology (2004) 2.16
Statin use and the risk of breast and prostate cancer. Epidemiology (2002) 2.15
Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation (2005) 2.13
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf (2002) 2.12
Differences in facial expressions of four universal emotions. Psychiatry Res (2004) 2.11
White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin Transl Sci (2010) 2.09
Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol (2011) 2.09
Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation (2003) 2.07
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation (2009) 2.06
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis (2008) 2.03
Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med (2003) 2.02
Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am J Public Health (2004) 2.02
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail (2011) 2.01
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis (2006) 1.96
Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol (2003) 1.95
Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol (2004) 1.94
Impact of primary graft failure on outcomes following lung transplantation. Chest (2005) 1.92
Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest (2003) 1.90
A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitudes and Behaviors. Arch Sex Behav (2006) 1.87
Medication adherence: a call for action. Am Heart J (2011) 1.85
Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol (2009) 1.85
Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant (2010) 1.85
Geographic variation in pharmacotherapy decisions for U.S. Medicare enrollees with diabetes. J Diabetes Complications (2012) 1.84
Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics (2011) 1.84
Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis (2004) 1.83
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care (2011) 1.83
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med (2005) 1.82
Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol (2004) 1.81